Proven Clinical Results.
Proven Clinical Utility.
Clinical Trial (350 wounds)
Increased Diagnostic Sensitivity1
A multisite, prospective clinical trial of chronic wounds (n=350 wounds, 14 sites and 20 clinicians) reported a 4-fold increase in sensitivity for detecting bacterial loads of >104 CFU/g (typically moderate-to-heavy growth) when MolecuLight i:Xfl uorescence was added to standard-of-care, compared to clinical signs and symptoms (CSS) alone1.
Clinical Study (350 wounds)
Diagnostic Accuracy of Fluorescence Images2
Red Fluorescence
- Positive Predictive Value 95%
- Sensitivity 100%
- Specificity 78%
Cyan Fluorescence
- Sensitivity 100%
- Specificity 100%
MolecuLight was recently featured in:
Training Videos
View our training videos designed to help wound care professionals understand how to operate the MolecuLight i:X device, its various capabilities (digital wound area measurement, detection of wounds containing elevated bacterial burden (>104 CFU/g), along with CSS), and its accessories.
References
1 American Diabetes Society, Diagnosis and Management of Diabetic Foot Infections, 2020
2 Heather L. Orsted et al., Foundations of Best Practice for Skin and Wound Management Skin: Anatomy, Physiology and Wound Healing
3 Robson MC et al., Guidelines for the treatment of venous ulcers. Wound Repair Regen. 2006 Nov-Dec;14(6):649-62
4 Emily Haesler et al., National Pressure Ulcer Advisory Panel, European Pressure Ulcer Advisory Panel and Pan Pacific Pressure Injury Alliance. Prevention and Treatment of Pressure Ulcers: Clinical Practice Guideline, 2014
5 O’Donnell TF et al., Society for Vascular Surgery; American Venous Forum. Management of venous leg ulcers: clinical practice guidelines of the Society for Vascular Surgery, J Vasc Surg. 2014 Aug;60(2 Suppl):3S-59S
6 American Diabetes Society Diagnosis and Management of Diabetic Foot Infections, 2020
7 Emily Haesler et al., National Pressure Ulcer Advisory Panel, European Pressure Ulcer Advisory Panel and Pan Pacific Pressure Injury Alliance. Prevention and Treatment of Pressure Ulcers: Clinical Practice Guideline, 2014
8 Connie L. Harris et al., Best Practice Recommendations for the Prevention and Management of Surgical Wound Complications
10 Martin C. Robson et al., Guidelines for the treatment of venous ulcers
11 O’Donnell TF Jr et al., Society for Vascular Surgery; American Venous Forum. Management of venous leg ulcers: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg. 2014 Aug;60(2Suppl):3S-59S
12 Ousey K. et al., International Consensus Document: Identifying and treating foot ulcers in patients with diabetes: saving feet, legs and lives. J Wound Care 2018; 27
13, 19, 23 Emily Haesler et al., National Pressure Ulcer Advisory Panel, European Pressure Ulcer Advisory Panel and Pan Pacific Pressure Injury Alliance. Prevention and Treatment of Pressure Ulcers: Clinical Practice Guideline, 2014
14 Hopf HW et al., Guidelines for the treatment of arterial insufficiency ulcers. Wound Repair Regen. 2006 Nov-Dec;14(6):693-710
15, 16, 20 Whitney J, et al., Guidelines for the treatment of pressure ulcers. Wound Repair Regen. 2006 Nov-Dec;14(6):663-79
21 Atkin L. et al., Implementing TIMERS: the race against hard-to-heal wounds. J Wound Care 2019; 28(3 Suppl 3):S1–S49